These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36580964)
1. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis. Wang J; Xiang C; Cai Y; Mei Z; Lu Q; Liu B; Zou L Arq Neuropsiquiatr; 2022 Dec; 80(12):1254-1261. PubMed ID: 36580964 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis. Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004 [TBL] [Abstract][Full Text] [Related]
3. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis. Zhou Y; Wang X; Liu Z; Huang X; Li X; Cheng K; Jiang X Clin Neurol Neurosurg; 2019 Jan; 176():103-109. PubMed ID: 30554090 [TBL] [Abstract][Full Text] [Related]
4. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis. Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470 [TBL] [Abstract][Full Text] [Related]
5. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis. Wu B; Sun C; Feng F; Ge M; Xia L J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234 [TBL] [Abstract][Full Text] [Related]
6. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis. Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671 [TBL] [Abstract][Full Text] [Related]
7. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis. Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935 [TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma. Wang J; Yang CL; Zou LL Mol Clin Oncol; 2017 Nov; 7(5):885-890. PubMed ID: 29075491 [TBL] [Abstract][Full Text] [Related]
9. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis. Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993 [TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies. Luo H; Li H; Yao N; Hu L; He T Tumour Biol; 2014 Jun; 35(6):5823-32. PubMed ID: 24599674 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved. Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation. Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of S100A14 expression in cancer patients: A meta-analysis. Hu L; Kong F; Pan Y Medicine (Baltimore); 2019 Jul; 98(28):e16356. PubMed ID: 31305429 [TBL] [Abstract][Full Text] [Related]
14. CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis. Ding X; Yang L; Geng X; Zou Y; Wang Z; Li Y; Qi R; Wang W; Li J; Yu H BMC Cancer; 2020 Oct; 20(1):1005. PubMed ID: 33059605 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients. Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713 [TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of microRNA-210 in various carcinomas: Evidence from 19 studies. Liu Y; Wang Y; Xu Q; Zhou X; Qin Z; Chen C; Zhang Q; Tian Y; Zhang C; Li X; Qin C Medicine (Baltimore); 2017 Oct; 96(43):e8113. PubMed ID: 29068983 [TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas. Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265 [TBL] [Abstract][Full Text] [Related]
19. EZH2 overexpression is associated with poor prognosis in patients with glioma. Zhang Y; Yu X; Chen L; Zhang Z; Feng S Oncotarget; 2017 Jan; 8(1):565-573. PubMed ID: 27880940 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological significance of long non-coding RNA in glioma. Li J; Liang R; Song C; Xiang Y; Liu Y Neurosurg Rev; 2020 Feb; 43(1):1-8. PubMed ID: 29564570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]